AtriCure (ATRC) Misses Q2 EPS by 3c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- S&P 500, Nasdaq end sharply lower as revived AI doubts ignite tech selloff
- Meta’s new Class C stock to keep Zuckerberg in California, fund AI spending spree
- Oil hits five-month high as Houthi attacks stoke supply fears
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
Tweet
Share
E-mailGet Alerts ATRC Hot Sheet
Price: $59.30 +2.83%
Revenue Growth %: +12.5%
Financial Fact:
Income tax expense (benefit): 2K
Today's EPS Names:
ORPB, PBCO, SICP, More
Revenue Growth %: +12.5%
Financial Fact:
Income tax expense (benefit): 2K
Today's EPS Names:
ORPB, PBCO, SICP, More
Join SI Premium – FREE
AtriCure (NASDAQ: ATRC) reported Q2 EPS of ($0.32), $0.03 worse than the analyst estimate of ($0.29). Revenue for the quarter came in at $84.5 million versus the consensus estimate of $79.67 million.
GUIDANCE:
AtriCure sees FY2022 EPS of ($1.07)-($1.12), versus the consensus of ($1.10). AtriCure sees FY2022 revenue of $323-333 million, versus the consensus of $324.43 million.
For earnings history and earnings-related data on AtriCure (ATRC) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Bloom Energy Corp. (BE) Tops Q3 EPS by 25c, Beats on Revenue; Offers FY26 Guidance
- Bloom Energy shares fall despite beating Q3 estimates
- AppFolio (APPF) Tops Q3 EPS by 3c; Offers Outlook
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
